美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Estrella Immunopharma

1.01

+0.01001.00%

成交量：4,883.00

成交額：4,950.42

市值：3,743.62萬

市盈率：-3.05

高：1.05

開：1.02

低：1.00

收：1.00

52周最高：1.78

52周最低：0.6300

股本：3,706.56萬

流通股本：1,098.55萬

量比：0.13

換手率：0.04%

股息：- -

股息率：- -

每股收益(TTM):-0.3309

每股收益(LYR):-0.1212

淨資產收益率：-268.50%

總資產收益率：-100.93%

市淨率：-6.14

市盈率(LYR):-8.33

資料載入中...

總覽公司新聞公告

Estrella Immunopharma, Inc.盤中異動股價大漲7.16%報0.985美元

Estrella Immunopharma, Inc.盤中異動急速上漲5.71%報0.870美元

Estrella Immunopharma, Inc.盤中異動股價大漲5.02%報0.870美元

Estrella Immunopharma, Inc.盤中異動股價大跌5.87%報0.805美元

Estrella Immunopharma, Inc.盤中異動股價大跌5.14%

Estrella Immunopharma, Inc.盤中異動早盤股價大跌6.99%報0.874美元

Estrella Immunopharma, Inc.盤中異動股價大漲5.50%報0.950美元

Estrella Immunopharma, Inc.盤中異動早盤股價大漲5.63%報0.923美元

Estrella Immunopharma, Inc.盤中異動臨近收盤大幅上漲7.83%報0.920美元

Estrella Immunopharma, Inc.盤中異動早盤快速跳水5.08%報0.840美元

Estrella Immunopharma, Inc.盤中異動早盤大幅下跌7.86%

Estrella Immunopharma, Inc.盤中異動股價大跌6.75%

Estrella Immunopharma, Inc.盤中異動早盤股價大漲8.97%

Estrella Immunopharma, Inc.盤中異動快速上漲7.95%報0.950美元

Estrella Immunopharma, Inc.股價拉昇11.42% 市值跌2.18萬美元

Estrella Immunopharma, Inc.盤中異動早盤快速下跌6.36%

Estrella Immunopharma, Inc.盤中異動早盤股價大跌6.37%報0.880美元

Estrella Immunopharma, Inc.盤中異動大幅上漲5.87%

Estrella Immunopharma, Inc.盤中異動股價大跌7.07%報0.920美元

Estrella Immunopharma, Inc.盤中異動股價大漲7.75%報1.004美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ESLA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.01,"timestamp":1757443366344,"preClose":1,"halted":0,"volume":4883,"delay":0,"floatShares":10985451,"shares":37065589,"eps":-0.330901,"marketStatus":"交易中","change":0.01,"latestTime":"09-09 14:45:39 EDT","open":1.02,"high":1.0515,"low":1,"amount":4950.4161629,"amplitude":0.0515,"askPrice":1.06,"askSize":32,"bidPrice":1.01,"bidSize":122,"shortable":3,"etf":0,"ttmEps":-0.330901,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1757448000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1,"postHourTrading":{"tag":"盘后","latestPrice":1.03,"preClose":1,"latestTime":"19:41 EDT","volume":789,"amount":812.55,"timestamp":1757374862262},"volumeRatio":0.125361},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","floatShares":10985451,"roa":"-100.93%","roe":"-268.50%","lyrEps":-0.121236,"volumeRatio":0.125361,"shares":37065589,"dividePrice":0,"high":1.0515,"amplitude":0.0515,"preClose":1,"low":1,"week52Low":0.63,"pbRate":"-6.14","week52High":1.78,"institutionHeld":0,"latestPrice":1.01,"committee":0.584416,"eps":-0.330901,"divideRate":0,"volume":4883,"delay":0,"ttmEps":-0.330901,"open":1.02,"prevYearClose":1.2,"prevWeekClose":1.05,"prevMonthClose":1.05,"prevQuarterClose":0.96,"fiveDayClose":1.07,"twentyDayClose":0.865,"sixtyDayClose":1.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"ESLA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740110400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ESLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ESLA","date":"2025-09-08","current":-3.221056,"percent":0.901316,"low":-10.568666,"twenty":-5.432465,"median":-4.46488,"eighty":-3.765837,"high":-2.54331,"avg":-4.657954,"sd":1.252816,"marketCap":38918868},"quantilePoints":[{"date":"2023-10-13","current":-4.972461,"twenty":-6.796753,"median":-5.384194,"eighty":-5.200498,"marketCap":55265934},{"date":"2023-10-20","current":-4.346628,"twenty":-5.624899,"median":-4.845774,"eighty":-4.503973,"marketCap":48310170},{"date":"2023-10-27","current":-4.814103,"twenty":-5.358857,"median":-4.766595,"eighty":-4.395592,"marketCap":53505872},{"date":"2023-11-03","current":-4.877446,"twenty":-5.358857,"median":-4.877446,"eighty":-4.546793,"marketCap":54209897},{"date":"2023-11-10","current":-4.085653,"twenty":-5.257507,"median":-4.829938,"eighty":-4.367404,"marketCap":45409589},{"date":"2023-11-17","current":-3.800607,"twenty":-5.219501,"median":-4.560729,"eighty":-4.142662,"marketCap":42241478},{"date":"2023-11-24","current":-4.914497,"twenty":-5.067477,"median":-4.560729,"eighty":-4.117325,"marketCap":49633737},{"date":"2023-12-01","current":-5.785861,"twenty":-5.257507,"median":-4.829938,"eighty":-4.244012,"marketCap":58434045},{"date":"2023-12-08","current":-4.18255,"twenty":-5.193333,"median":-4.719087,"eighty":-4.244012,"marketCap":42241478},{"date":"2023-12-15","current":-4.356823,"twenty":-5.067477,"median":-4.653087,"eighty":-4.244012,"marketCap":44001540},{"date":"2023-12-22","current":-4.321969,"twenty":-5.053915,"median":-4.560729,"eighty":-4.244012,"marketCap":43649527},{"date":"2023-12-29","current":-4.008277,"twenty":-5.005043,"median":-4.502348,"eighty":-4.203463,"marketCap":40481416},{"date":"2024-01-05","current":-4.043132,"twenty":-4.967839,"median":-4.461387,"eighty":-4.18255,"marketCap":40833429},{"date":"2024-01-12","current":-3.520313,"twenty":-4.949351,"median":-4.397024,"eighty":-4.086666,"marketCap":35553244},{"date":"2024-01-19","current":-3.555168,"twenty":-4.949351,"median":-4.37517,"eighty":-4.043132,"marketCap":35905256},{"date":"2024-01-26","current":-4.217405,"twenty":-4.914497,"median":-4.391678,"eighty":-4.043132,"marketCap":42593490},{"date":"2024-02-02","current":-4.217405,"twenty":-4.914497,"median":-4.356823,"eighty":-4.022309,"marketCap":42593490},{"date":"2024-02-09","current":-4.008626,"twenty":-4.879642,"median":-4.356475,"eighty":-4.008626,"marketCap":40484936},{"date":"2024-02-16","current":-3.79915,"twenty":-4.877446,"median":-4.314662,"eighty":-4.008277,"marketCap":38369342},{"date":"2024-02-23","current":-4.421106,"twenty":-4.852108,"median":-4.351551,"eighty":-4.008277,"marketCap":36976978},{"date":"2024-03-01","current":-4.46488,"twenty":-4.845774,"median":-4.356823,"eighty":-4.008556,"marketCap":37343087},{"date":"2024-03-08","current":-4.683308,"twenty":-4.845774,"median":-4.37517,"eighty":-4.008626,"marketCap":39169969},{"date":"2024-03-15","current":-4.508653,"twenty":-4.845774,"median":-4.391678,"eighty":-4.019572,"marketCap":37709196},{"date":"2024-03-22","current":-4.727519,"twenty":-4.845774,"median":-4.421106,"eighty":-4.038967,"marketCap":39539739},{"date":"2024-03-28","current":-5.471666,"twenty":-4.878324,"median":-4.421106,"eighty":-4.043132,"marketCap":45763587},{"date":"2024-04-05","current":-4.990159,"twenty":-4.946386,"median":-4.434042,"eighty":-4.068645,"marketCap":41736391},{"date":"2024-04-12","current":-4.771293,"twenty":-4.947572,"median":-4.461387,"eighty":-4.088693,"marketCap":39905848},{"date":"2024-04-19","current":-4.508653,"twenty":-4.946386,"median":-4.46488,"eighty":-4.106683,"marketCap":37709196},{"date":"2024-04-26","current":-4.552426,"twenty":-4.946123,"median":-4.508653,"eighty":-4.135548,"marketCap":38075304},{"date":"2024-05-03","current":-4.604954,"twenty":-4.927077,"median":-4.543309,"eighty":-4.168608,"marketCap":38514635},{"date":"2024-05-10","current":-4.683746,"twenty":-4.914497,"median":-4.525981,"eighty":-4.18255,"marketCap":39173630},{"date":"2024-05-17","current":-6.309978,"twenty":-4.927077,"median":-4.552426,"eighty":-4.18255,"marketCap":38441413},{"date":"2024-05-24","current":-6.009503,"twenty":-4.949351,"median":-4.552645,"eighty":-4.18255,"marketCap":36610870},{"date":"2024-05-31","current":-5.254478,"twenty":-5.016423,"median":-4.56334,"eighty":-4.196492,"marketCap":32011137},{"date":"2024-06-07","current":-5.573329,"twenty":-5.126143,"median":-4.595762,"eighty":-4.217405,"marketCap":33953631},{"date":"2024-06-14","current":-5.672448,"twenty":-5.245388,"median":-4.604954,"eighty":-4.217405,"marketCap":34557478},{"date":"2024-06-21","current":-5.254478,"twenty":-5.254478,"median":-4.639973,"eighty":-4.217405,"marketCap":32011137},{"date":"2024-06-28","current":-5.553028,"twenty":-5.257507,"median":-4.639973,"eighty":-4.217405,"marketCap":33829952},{"date":"2024-07-05","current":-6.836793,"twenty":-5.380881,"median":-4.661859,"eighty":-4.222726,"marketCap":41650855},{"date":"2024-07-12","current":-8.120557,"twenty":-5.46684,"median":-4.674942,"eighty":-4.245731,"marketCap":49471758},{"date":"2024-07-15","current":-8.478817,"twenty":-5.484657,"median":-4.679369,"eighty":-4.24745,"marketCap":51654336},{"date":"2024-08-02","current":-10.568666,"twenty":-5.500483,"median":-4.681339,"eighty":-4.24917,"marketCap":64386038},{"date":"2024-08-09","current":-8.299687,"twenty":-5.526159,"median":-4.683746,"eighty":-4.266453,"marketCap":50563047},{"date":"2024-08-16","current":-8.419107,"twenty":-5.589093,"median":-4.694558,"eighty":-4.282332,"marketCap":51290573},{"date":"2024-08-23","current":-7.881717,"twenty":-5.717813,"median":-4.727519,"eighty":-4.286974,"marketCap":48016706},{"date":"2024-08-30","current":-6.896503,"twenty":-6.017985,"median":-4.738462,"eighty":-4.287114,"marketCap":42014618},{"date":"2024-09-06","current":-6.329258,"twenty":-6.201587,"median":-4.792698,"eighty":-4.288183,"marketCap":38558870},{"date":"2024-09-13","current":-7.045778,"twenty":-6.309738,"median":-4.815066,"eighty":-4.296814,"marketCap":42924025},{"date":"2024-09-20","current":-5.76261,"twenty":-6.309738,"median":-4.815066,"eighty":-4.313201,"marketCap":35106760},{"date":"2024-09-27","current":-5.791271,"twenty":-6.293445,"median":-4.845774,"eighty":-4.331833,"marketCap":35281366},{"date":"2024-10-04","current":-5.494176,"twenty":-6.293445,"median":-4.868142,"eighty":-4.350567,"marketCap":40171894},{"date":"2024-10-11","current":-4.148845,"twenty":-6.216784,"median":-4.858839,"eighty":-4.350567,"marketCap":30335209},{"date":"2024-10-18","current":-4.157755,"twenty":-6.122441,"median":-4.845774,"eighty":-4.288183,"marketCap":30400352},{"date":"2024-10-25","current":-4.212202,"twenty":-6.099645,"median":-4.815066,"eighty":-4.286905,"marketCap":30798452},{"date":"2024-10-31","current":-4.032032,"twenty":-6.085858,"median":-4.815066,"eighty":-4.286835,"marketCap":29481103},{"date":"2024-11-08","current":-3.964716,"twenty":-6.030708,"median":-4.792698,"eighty":-4.245731,"marketCap":28988907},{"date":"2024-11-15","current":-4.157755,"twenty":-6.026467,"median":-4.727519,"eighty":-4.217405,"marketCap":30400352},{"date":"2024-11-22","current":-3.652759,"twenty":-6.001802,"median":-4.723303,"eighty":-4.18255,"marketCap":32209897},{"date":"2024-11-29","current":-4.656782,"twenty":-5.970998,"median":-4.694558,"eighty":-4.18255,"marketCap":41063331},{"date":"2024-12-06","current":-5.005528,"twenty":-5.961427,"median":-4.719087,"eighty":-4.18255,"marketCap":44138559},{"date":"2024-12-13","current":-5.066661,"twenty":-5.907942,"median":-4.727519,"eighty":-4.18255,"marketCap":44677628},{"date":"2024-12-20","current":-4.513181,"twenty":-5.895445,"median":-4.727519,"eighty":-4.18255,"marketCap":39797061},{"date":"2024-12-27","current":-4.800383,"twenty":-5.891211,"median":-4.759354,"eighty":-4.202312,"marketCap":42329601},{"date":"2025-01-03","current":-4.595649,"twenty":-5.831182,"median":-4.759354,"eighty":-4.210222,"marketCap":40524262},{"date":"2025-01-10","current":-4.55421,"twenty":-5.791868,"median":-4.759354,"eighty":-4.214283,"marketCap":40158853},{"date":"2025-01-17","current":-4.808589,"twenty":-5.791868,"median":-4.765324,"eighty":-4.217405,"marketCap":42401960},{"date":"2025-01-24","current":-4.841412,"twenty":-5.791749,"median":-4.765324,"eighty":-4.217405,"marketCap":42691393},{"date":"2025-01-31","current":-4.595239,"twenty":-5.790189,"median":-4.759354,"eighty":-4.217405,"marketCap":40520644},{"date":"2025-02-07","current":-4.718325,"twenty":-5.781211,"median":-4.75438,"eighty":-4.222726,"marketCap":41606019},{"date":"2025-02-14","current":-4.636268,"twenty":-5.75842,"median":-4.727519,"eighty":-4.245731,"marketCap":40882436},{"date":"2025-02-21","current":-6.113309,"twenty":-5.785861,"median":-4.749406,"eighty":-4.252608,"marketCap":53906929},{"date":"2025-02-28","current":-3.938776,"twenty":-5.785861,"median":-4.75438,"eighty":-4.252608,"marketCap":34731981},{"date":"2025-03-07","current":-4.061863,"twenty":-5.76261,"median":-4.727519,"eighty":-4.217405,"marketCap":35817355},{"date":"2025-03-14","current":-4.184949,"twenty":-5.741662,"median":-4.718911,"eighty":-4.212202,"marketCap":36902729},{"date":"2025-03-21","current":-3.781635,"twenty":-5.692164,"median":-4.717095,"eighty":-4.184949,"marketCap":33346319},{"date":"2025-03-28","current":-3.800136,"twenty":-5.672448,"median":-4.683746,"eighty":-4.18255,"marketCap":33646606},{"date":"2025-04-04","current":-3.839558,"twenty":-5.66199,"median":-4.683746,"eighty":-4.157755,"marketCap":33995653},{"date":"2025-04-11","current":-3.717019,"twenty":-5.653341,"median":-4.678332,"eighty":-4.145266,"marketCap":32910685},{"date":"2025-04-17","current":-3.41639,"twenty":-5.652863,"median":-4.673905,"eighty":-4.117991,"marketCap":30248898},{"date":"2025-04-25","current":-3.921251,"twenty":-5.627318,"median":-4.661859,"eighty":-4.100129,"marketCap":34718965},{"date":"2025-05-02","current":-4.656485,"twenty":-5.620962,"median":-4.656633,"eighty":-4.100129,"marketCap":41228771},{"date":"2025-05-09","current":-4.738178,"twenty":-5.614383,"median":-4.656485,"eighty":-4.103875,"marketCap":41952083},{"date":"2025-05-16","current":-3.800286,"twenty":-5.606051,"median":-4.639973,"eighty":-4.100129,"marketCap":33999270},{"date":"2025-05-23","current":-3.448008,"twenty":-5.579539,"median":-4.636268,"eighty":-4.061863,"marketCap":36165589},{"date":"2025-05-30","current":-4.166329,"twenty":-5.561148,"median":-4.636268,"eighty":-4.061535,"marketCap":36888900},{"date":"2025-06-06","current":-4.329714,"twenty":-5.553028,"median":-4.610297,"eighty":-4.04971,"marketCap":38335524},{"date":"2025-06-13","current":-4.125482,"twenty":-5.553028,"median":-4.595762,"eighty":-4.04971,"marketCap":36527244},{"date":"2025-06-20","current":-3.80443,"twenty":-5.54228,"median":-4.595239,"eighty":-4.043395,"marketCap":33684629},{"date":"2025-06-27","current":-3.241128,"twenty":-5.526159,"median":-4.580844,"eighty":-4.026198,"marketCap":33995653},{"date":"2025-07-03","current":-3.034247,"twenty":-5.524015,"median":-4.570132,"eighty":-4.008754,"marketCap":31825718},{"date":"2025-07-11","current":-3.185615,"twenty":-5.515089,"median":-4.55421,"eighty":-4.008277,"marketCap":33413387},{"date":"2025-07-18","current":-2.827711,"twenty":-5.513197,"median":-4.552645,"eighty":-3.966457,"marketCap":29659399},{"date":"2025-07-25","current":-3.273884,"twenty":-5.50782,"median":-4.552426,"eighty":-3.959029,"marketCap":34339226},{"date":"2025-08-01","current":-2.896327,"twenty":-5.494176,"median":-4.538015,"eighty":-3.922458,"marketCap":30379094},{"date":"2025-08-08","current":-2.903223,"twenty":-5.494004,"median":-4.513181,"eighty":-3.885066,"marketCap":30451425},{"date":"2025-08-15","current":-2.639426,"twenty":-5.488988,"median":-4.510917,"eighty":-3.835115,"marketCap":31891232},{"date":"2025-08-22","current":-2.699552,"twenty":-5.46684,"median":-4.508653,"eighty":-3.80035,"marketCap":32617718},{"date":"2025-08-29","current":-2.944966,"twenty":-5.444751,"median":-4.482671,"eighty":-3.7826,"marketCap":35582965},{"date":"2025-09-05","current":-3.313087,"twenty":-5.433608,"median":-4.465996,"eighty":-3.769203,"marketCap":40030836},{"date":"2025-09-08","current":-3.221056,"twenty":-5.432465,"median":-4.46488,"eighty":-3.765837,"marketCap":38918868}],"updateTime":1757420179606},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560438124","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲7.16%報0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560438124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560438124?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 02:41","pubTimestamp":1755628861,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日02时41分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨7.16%。截至发稿，该股报0.985美元/股，成交量591股，换手率0.00%，振幅4.02%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.97%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082002410197521bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082002410197521bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2558866168","title":"Estrella Immunopharma, Inc.盤中異動 急速上漲5.71%報0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558866168?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 23:22","pubTimestamp":1754925766,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时22分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.71%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5561.67%、490.85%、169.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232247a4823ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232247a4823ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2557313410","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲5.02%報0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557313410?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 00:25","pubTimestamp":1754411132,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时25分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.02%。截至发稿，该股报0.870美元/股，成交量2168股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为3.18%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600253294d1a0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600253294d1a0af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2556380934","title":"Estrella Immunopharma, Inc.盤中異動 股價大跌5.87%報0.805美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556380934?lang=zh_tw&edition=fundamental","pubTime":"2025-08-04 22:32","pubTimestamp":1754317961,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时32分，Estrella Immunopharma, Inc.股票出现异动，股价大幅跳水5.87%。截至发稿，该股报0.805美元/股，成交量2680股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804223241a6d29adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804223241a6d29adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2556837183","title":"Estrella Immunopharma, Inc.盤中異動 股價大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556837183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556837183?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 00:42","pubTimestamp":1753980146,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时42分，Estrella Immunopharma, Inc.股票出现异动，股价大幅跳水5.14%。截至发稿，该股报0.830美元/股，成交量3145股，换手率0.01%，振幅4.29%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为2.91%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801004227a6cc0cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801004227a6cc0cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2555040059","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大跌6.99%報0.874美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555040059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555040059?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 22:30","pubTimestamp":1753885806,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时30分，Estrella Immunopharma, Inc.股票出现异动，股价急速下跌6.99%。截至发稿，该股报0.874美元/股，成交量2215股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730223006a46bc8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730223006a46bc8d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2554780443","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲5.50%報0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554780443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554780443?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 03:59","pubTimestamp":1753387160,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日03时59分，Estrella Immunopharma, Inc.股票出现异动，股价快速上涨5.50%。截至发稿，该股报0.950美元/股，成交量1.1778万股，换手率0.03%，振幅7.52%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725035920971cb18b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725035920971cb18b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2553671245","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大漲5.63%報0.923美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553671245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553671245?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 21:31","pubTimestamp":1753277498,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日21时31分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.63%。截至发稿，该股报0.923美元/股，成交量5380股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723213139a45f0e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723213139a45f0e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2553409435","title":"Estrella Immunopharma, Inc.盤中異動 臨近收盤大幅上漲7.83%報0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553409435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553409435?lang=zh_tw&edition=fundamental","pubTime":"2025-07-22 03:45","pubTimestamp":1753127130,"startTime":"0","endTime":"0","summary":"北京时间2025年07月22日03时45分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升7.83%。截至发稿，该股报0.920美元/股，成交量9905股，换手率0.03%，振幅6.80%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722034530a45a6efa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722034530a45a6efa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2551198097","title":"Estrella Immunopharma, Inc.盤中異動 早盤快速跳水5.08%報0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551198097?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 22:16","pubTimestamp":1752589009,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时16分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.08%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221649a6ab689d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221649a6ab689d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2551184131","title":"Estrella Immunopharma, Inc.盤中異動 早盤大幅下跌7.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551184131?lang=zh_tw&edition=fundamental","pubTime":"2025-07-14 21:52","pubTimestamp":1752501147,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时52分，Estrella Immunopharma, Inc.股票出现异动，股价快速下挫7.86%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1741.19%、624.89%、471.59%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为163.93%、115.31%、87.78%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215227954230d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215227954230d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2550506939","title":"Estrella Immunopharma, Inc.盤中異動 股價大跌6.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550506939?lang=zh_tw&edition=fundamental","pubTime":"2025-07-11 23:58","pubTimestamp":1752249517,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日23时58分，Estrella Immunopharma, Inc.股票出现波动，股价大幅下挫6.75%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711235838a4453430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711235838a4453430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2550626440","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大漲8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550626440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550626440?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 21:55","pubTimestamp":1752155701,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时55分，Estrella Immunopharma, Inc.股票出现异动，股价快速上涨8.97%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710215501a442bf79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710215501a442bf79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2549563805","title":"Estrella Immunopharma, Inc.盤中異動 快速上漲7.95%報0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549563805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549563805?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 23:19","pubTimestamp":1751901544,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日23时19分，Estrella Immunopharma, Inc.股票出现异动，股价大幅拉升7.95%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为4857.48%、1155.64%、845.14%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、146.56%、84.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707231905a43c1c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707231905a43c1c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2548817137","title":"Estrella Immunopharma, Inc.股價拉昇11.42% 市值跌2.18萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548817137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548817137?lang=zh_tw&edition=fundamental","pubTime":"2025-07-03 03:56","pubTimestamp":1751486212,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升11.42%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2547101348","title":"Estrella Immunopharma, Inc.盤中異動 早盤快速下跌6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547101348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547101348?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 22:55","pubTimestamp":1751295338,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时55分，Estrella Immunopharma, Inc.股票出现波动，股价快速跳水6.36%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302255389531640f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302255389531640f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2546774745","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大跌6.37%報0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546774745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546774745?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 23:12","pubTimestamp":1751037121,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日23时12分，Estrella Immunopharma, Inc.股票出现波动，股价大幅下跌6.37%。截至发稿，该股报0.880美元/股，成交量1078股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627231201a4c180b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627231201a4c180b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2545231548","title":"Estrella Immunopharma, Inc.盤中異動 大幅上漲5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545231548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545231548?lang=zh_tw&edition=fundamental","pubTime":"2025-06-24 23:42","pubTimestamp":1750779757,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时42分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升5.87%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624234238a71b8027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624234238a71b8027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2545101034","title":"Estrella Immunopharma, Inc.盤中異動 股價大跌7.07%報0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545101034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545101034?lang=zh_tw&edition=fundamental","pubTime":"2025-06-23 21:32","pubTimestamp":1750685572,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时32分，Estrella Immunopharma, Inc.股票出现波动，股价快速下挫7.07%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Impact Biomedical, Inc.、Cidara Therapeutics, Inc.、Indaptus Therapeutics, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为900.47%、898.95%、200.36%，振幅较大的相关个股有Impact Biomedical, Inc.、Skye Bioscience, Inc.、Indaptus Therapeutics, Inc.，振幅分别为30.38%、19.44%、16.55%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213252a718f170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213252a718f170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2545177590","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲7.75%報1.004美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545177590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545177590?lang=zh_tw&edition=fundamental","pubTime":"2025-06-21 02:50","pubTimestamp":1750445456,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日02时50分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升7.75%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062102505697884b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062102505697884b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}